Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.
|Slideshows|November 7, 2018
To Increase-or Not to Increase-the Dose?
Author(s)Brian Miller, MD, PhD, MPH
A brief discussion of dose increase versus unchanged continuation of antidepressants after initial treatment failure in patients with depression.
Advertisement
Advertisement
Related to this article
Phase 3 psilocybin and LSD data plus new FDA guidance fuel a depression boom—yet clinics still wrestle with dosing time, cost, access.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The First Ever Treatment-Resistant Depression Awareness Day
2
What Makes Us Human? The Role of Psychiatry and the Future DSM
3
Antipsychotic Plasma Levels in Schizophrenia: Detecting Nonadherence and Guiding Dose Decisions
4
How Best to Manage Treatment-Resistant Depression
5